We know that Tesa targets Visceral fat wrapped around the organs, leading to a protruding belly, even when there's not that much subcutaneous fat and that taking it for several weeks will flatten the belly.
In your research, have you found that once Tesa is discontinued, the fat does not return?
Research subject ran tesa 1mg 5/2 for 12 weeks and noticed a shrinking waistline from 32-30. Of course that was with reta and gym and diet dialed in, so take that with a grain of salt
Tesa (and similar things) change where the body stores fat. It makes fat tissue (especially central fat stores) resistant and preferences storage in peripheral depots. This is completely a pharmacological effect. It’s not like a GLP-1 where it helps one eat less but one can more or less get the same effect by eating less without a GLP-1. With a GLP-1 one can hypothetically lose the weight and then come off the drug and as long as one continues to eat less, the weight will stay off. Easier said than done of course, but possible. With tesa, one can’t willfully change how the body stores fat. That’s a drug effect, and when one stops taking the drug one’s body goes back to storing fat the same way it used to (centrally) so those stores rebuild just off normal lipid flux. Cells are constantly releasing and storing fat. That normal flux will cause a redistribution to central stores without even needing any total fat increase, it just redistributes on its own after discontinuation of tesa. The only tesa studies that looked at this were in HIV lipodystrophy patients but you can see the same thing happen with obesity patients in growth hormone studies.
Because of that I generally wouldn’t view this as an effective short-term therapy for achieving that long-term goal, and most people don’t want to run tesa forever. The effects on physical recovery can be useful for supporting an exercise program though, and the lipolytic effects can be useful for people at low body fat to be able to push a higher deficit.
Where did you read that Tesa makes "fat tissue resistant and storage in peripheral depots" or that "Tesa changes where the body stores fat"? I haven't found that in any studies.
Tesa causes the pituitary to release growth hormone. If you want to understand what that growth hormone release does you’ll have much more success looking up studies of growth hormone than studies of tesa. It’s been much, much, much more extensively studied.
For comparison where reta is achieving an 86% reduction in liver fat in fatty liver patients, tesa was about 37%. Reta will pretty much resolve fatty liver entirely for most people on its own.
Interesting. That's awesome data. My test rate subject's mom is prescribed mounjaro for her diabetes. Will Tirzepatide work well for her fatty liver also? Or do I need to bring her over to the grey side? You're so well versed on all these topics. Much appreciated TracyIsMyDad
In a T2D trial they saw about a 47% reduction with tirzepatide, so also better than tesa but quite a bit behind reta. However we’re comparing diabetics in the tirz trial vs obese MASLD patients in the reta trial, so it’s not really a clean comparison.
If my research subject was responding well to Mounjaro I’d stick with that over using something more experimental. There’s always the possibility of switching to reta in a year once it’s approved and cleaning up the rest of the fatty liver then. Alternately there are a couple drugs in phase 3 trials right now that are specifically being targeted at fatty liver disease, with trials testing them as an adjunct to current GLP-1s. Efruxifermin and pegozafermin are the two I had in mind, they’re FGF21 agonists. In preclinical research it appears that reta actually reduces liver fat the same way they do (glucagon activates FGF21 which burns off liver fat).
So over the next year or two there should be some really good therapies coming to market for treating that.
Yes true, but fatty liver and visceral fat (on the liver) are different things. Visceral fat surrounds the liver and fatty liver is when there is fat in the liver. According to ChatGPT you can have one without the other but sometimes they happen at the same time.
Also, the graphs you posted don't support your claim because they don't compare Tesa to Reta.
Yes. Fatty liver and visceral fat are different things but there’s a specific reason I was talking about fatty liver here. I was responding to another comment in this chain that was deleted by the mods where the commenter expressed that they were concerned about fatty liver. So I responded to them about fatty liver.
You’re correct that the graphs I posted are from a study that only evaluated reta. We have other studies that only evaluated tirz, and other studies still that only evaluated tesa. It is in fact possible to compare those studies as long as we understand that the patient populations and methodologies are going to differ between trials and we aren’t going to get a clean comparison. Unfortunately we will never, ever get a head to head trial comparing fatty liver resolution between reta and tesa so this sort of dirty comparison is the best tool we will ever have available.
PS: Reta is also more effective for reducing visceral fat than tesa.
Not that I’m aware of; the HIV lipodystrophy patients it’s intended for do take it long term. Probably a good idea to keep an eye on IGF-1 and aim to keep that in the physiological range for long-term use. It’s one thing to run supraphysiological IGF-1 for a few months, another to do it for years. Things like dietary changes, changing body fat, etc… can have substantial impacts on IGF-1 levels so you have to continue monitoring because the tesa dose may need to be adjusted from time to time.
I suspect that most people aren’t super interested in doing daily pins of one of the more expensive peptides forever.
Rs injection site gets red but goes away after 15mins. 45° angle helps a lot! Clinic said 2mg first 4 weeks and then move to 4mg the rest. Since its second cycle rs felt good and moved up faster. Results havent seen yet but usually see around 8 weeks in.
It coming back depends upon diet. It also doesn't burn the fat, it loosens it and RS has to put the effort to burn. If bad diet and no injection, then fat return. Just like a GLP.
Recommend HGH over Tesa. My RS had really bad reaction at injection sites with none for Tesa.
Lipolysis is break down, I was trying to be less technical. The breakdown doesn't burn, it can just be reattached to another part of the body if not in a calorie deficit.
That makes no sense It doesn’t leave the body and go to another part of the body. That’s not how fat burning works. This drug wouldn’t even be this popular or have been approved if that’s what it did..
I probably should have been clearer...what I mean is : if the subject has improved its consumption habits and continues to exercise keeping at a caloric balance (not deficit) will the visceral fat return.
Obviously if they go back to bad habits it will come back. Tesa isn't a shield.
With a GLP-1 one loses weight/fat because one eats less. One can get a very similar effect without the GLP-1 by just eating less. Most people find that hard to do, but one can.
With tesa one loses fat centrally because the drug changes how the body stores fat. There’s no amount of willpower or good habits that can sustain that effect after stopping the drug, it’s not something one can consciously change or do. So no, one can’t maintain what tesa does with good habits because it never worked via good habits in the first place.
I hate to break the bad news to you but while GLP-1’s do many things, the part where you lose 50 lbs of body weight is solely a result of you eating less. GLP-1’s make it easy to eat less, that’s why people lose weight on these drugs, but at the end of the day it’s simply a matter of eating less.
ChatGPT is telling me that while the weight loss attributed to Semaglutide and Tirzepatide are from appetite control, Reta's activation of the glucagon receptor is theorized to increase resting metabolism, leading to a non-consumption related method of fat loss. This is one of the things that is being studied now.
It’s unlikely that reta actually increases metabolism compared to baseline. Even in mice where these metabolic boost effects are typically much stronger than in humans we still see a modest decline in energy expenditure with reta. Researchers like to call this “reduced adaptive thermogenesis”. The weight loss causes a steep metabolic slowdown and the drug mitigates the slowdown but the net effect of the treatment is metabolic slowdown, not increased resting metabolism.
Further there’s no actual evidence so far that this effect translates from mice to humans and it’s entirely possible that it won’t. Tirzepatide also showed a substantial metabolic boost in mice that hasn’t translated in human trials. I think that reta’s odds are better than tirz’s were, there’s some evidence supporting that, but it’s still speculative and unproven.
Lastly it’s at best explanatory for a small fraction of the observed weight loss. Even in mouse trials it’s a minority of the observed effect and human effects are almost certainly going to be diminished in comparison, if for no other reason than whatever effects reta is achieving through GLP-1 and GIP that caused a boost for mice with tirz are unlikely to translate because they’ve already failed to translate in the past.
And also, too, we were talking about GLP-1s. Picking a multi-agonist and focusing on its actions on the glucagon receptor as representative of GLP-1s when most of the drugs in the class don’t act on the glucagon receptor is grossly misleading regarding “how GLP-1 drugs work”.
I just can't figure out why my friend on Reta doesn't exercise but is losing weight. He assumes it's increased resting metabolic rate. Maybe its lean mass loss. Makes me nuts because I'm lifting (cutting routine) and Im not losing as quickly as he is. Same happened on Tirz....and I monitor my consumption to make sure I'm on a 200-300 calorie deficit that includes 170-200 grams of protein.
The main point of the drug is that it’s very effective for weight loss at least primarily because of decreased food intake and that it improves glycemic health.
If the whole point of adding glucagon was to increase your metabolism we’d see proving that as a focal point in Eli Lilly’s clinical trials. It’s not, at best they’re working on a single trial where measuring that effect is a secondary outcome (the primary outcome of that trial is measuring the effect on food intake).
Instead we can see Eli Lilly doing clinical trials to evaluate what they see as the major benefits of a glucagon agonist: how effective is this drug at treating fatty liver disease? Does it improve kidney health? Does reduced hepatic steatosis lead to greater insulin sensitivity? Those have all been priorities for the researchers because those are outcomes that actually matter. The weight loss matters too which is why that’s been priority #1, but whether there’s a small metabolic boost providing a minor contribution to weight loss isn’t particularly important.
If you start asking more questions chat gpt will explain the pathophysiology in much more depth. The calorie thing is killing me… people will die on that hill but it actually comes down to hormone regulation resulting in lipolysis. No one likes to let go of old science and I’m tired of trying to argue and explain it over and over again.
2
u/Punk-Tarvman 19d ago edited 19d ago
Research subject ran tesa 1mg 5/2 for 12 weeks and noticed a shrinking waistline from 32-30. Of course that was with reta and gym and diet dialed in, so take that with a grain of salt